ATE318607T1 - Heparin-haltiges ophthalmikum - Google Patents

Heparin-haltiges ophthalmikum

Info

Publication number
ATE318607T1
ATE318607T1 AT02791625T AT02791625T ATE318607T1 AT E318607 T1 ATE318607 T1 AT E318607T1 AT 02791625 T AT02791625 T AT 02791625T AT 02791625 T AT02791625 T AT 02791625T AT E318607 T1 ATE318607 T1 AT E318607T1
Authority
AT
Austria
Prior art keywords
containing heparin
ophthalmic
ophthalmic containing
heparin
mucopolysaccharide
Prior art date
Application number
AT02791625T
Other languages
German (de)
English (en)
Inventor
Dorothea Gross
Frank Holzer
Original Assignee
Ursapharm Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ursapharm Arzneimittel Gmbh filed Critical Ursapharm Arzneimittel Gmbh
Application granted granted Critical
Publication of ATE318607T1 publication Critical patent/ATE318607T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT02791625T 2001-12-12 2002-12-11 Heparin-haltiges ophthalmikum ATE318607T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10161149A DE10161149B4 (de) 2001-12-12 2001-12-12 Verwendung von Heparin-haltigem Ophthalmikum

Publications (1)

Publication Number Publication Date
ATE318607T1 true ATE318607T1 (de) 2006-03-15

Family

ID=7709005

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02791625T ATE318607T1 (de) 2001-12-12 2002-12-11 Heparin-haltiges ophthalmikum

Country Status (11)

Country Link
US (1) US20050043271A1 (enExample)
EP (1) EP1453523B1 (enExample)
JP (1) JP2005513106A (enExample)
CN (1) CN1604784A (enExample)
AT (1) ATE318607T1 (enExample)
AU (1) AU2002357972A1 (enExample)
CA (1) CA2468775A1 (enExample)
DE (2) DE10161149B4 (enExample)
ES (1) ES2259727T3 (enExample)
MX (1) MXPA04005390A (enExample)
WO (1) WO2003053452A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001244713A1 (en) * 2000-04-03 2001-10-15 Santen Pharmaceutical Co. Ltd. Transporters and drug delivery system by using the same
WO2004093878A1 (en) * 2003-04-16 2004-11-04 Alcon, Inc. Use of fused pyridazine derivatives for treating dry eye disorders
DE10360425A1 (de) * 2003-12-19 2005-07-28 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
JP2005187407A (ja) * 2003-12-25 2005-07-14 Lion Corp アレルギー眼疾患用眼科組成物
DE102004002001A1 (de) 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
DE102006049091A1 (de) * 2006-10-18 2008-04-24 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl
FR2919185B1 (fr) 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
HRP20140862T1 (hr) * 2008-11-20 2014-11-07 Laboratori Derivati Organici S.P.A. Uporaba heparan sulfata u kozmetiäśkim i dermatološkim pripravcima
US20110065643A1 (en) 2009-06-12 2011-03-17 University Of Southern California Clusterin Pharmaceuticals and Treatment Methods Using the Same
FR2962044B1 (fr) * 2010-04-21 2013-02-22 Horus Pharma Emulsion lacrymimetique
JP2016185940A (ja) * 2014-06-10 2016-10-27 ロート製薬株式会社 眼科用組成物
DE102016203696A1 (de) * 2016-03-07 2017-09-07 Ursapharm Arzneimittel Gmbh Ophthalmologische Zusammensetzung
KR20190068575A (ko) * 2016-10-14 2019-06-18 이콤 메디칼 게엠베하 안구 표면 항상성의 확립, 회복 및 보존 방법
WO2019005222A1 (en) * 2017-06-29 2019-01-03 Advaite LLC. TREATMENT AND DIAGNOSIS OF OCULAR SURFACE DISORDERS
JP7333919B2 (ja) * 2017-09-05 2023-08-28 エクセル メッド、エルエルシー 虚血を治療するためのヘパリン組成物
SI3740191T1 (sl) * 2018-01-18 2021-09-30 Faes Farma, S.A. Očesna sestava, obsegajoča bilastin, beta ciklodekstrin in vsaj eno želirno sredstvo
CN112292135A (zh) 2018-04-18 2021-01-29 I.Com医疗有限责任公司 用于治疗和预防严重眼表疾病的高分子量透明质酸
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
CN116139067B (zh) * 2021-11-22 2024-03-22 华熙生物科技股份有限公司 透明质酸锌形成凝胶的方法及含有透明质酸锌的滴眼凝胶及其制备
WO2024024920A1 (ja) * 2022-07-29 2024-02-01 マルホ株式会社 眼科用組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1730M (fr) * 1962-01-17 1963-03-18 Charles Riviere Nouvelle composition de collyre.
DE3440352A1 (de) * 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye-packung
ATE93708T1 (de) * 1986-04-04 1993-09-15 Allergan Inc Zaehfluessiges praeparat zur anwendung bei wunden in der augenhornhaut.
JPS6479103A (en) * 1987-06-09 1989-03-24 Lion Corp External preparation
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
JPH02167233A (ja) * 1988-11-10 1990-06-27 Kiyoshi Kita 眼内手術補助剤
US5141741A (en) * 1988-12-09 1992-08-25 Lion Corporation Anti-sunburn skin-care preparation
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
DE19520575A1 (de) * 1995-06-06 1996-12-12 Permselect Ges Fuer Zellstrukt Hautwirksame Kombination von Mucopolysacchariden
DE19547972A1 (de) * 1995-12-21 1997-07-10 Weropharm Gmbh Heparin zur Prophylaxe und akuten Therapie der allergischen Konjunktivitis
US6372755B2 (en) * 1997-07-11 2002-04-16 Toray Industries, Inc. Stable medicinal compositions containing 4,5-epoxymorphinan derivatives
US6348508B1 (en) * 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye

Also Published As

Publication number Publication date
EP1453523B1 (de) 2006-03-01
CA2468775A1 (en) 2003-07-03
DE10161149B4 (de) 2007-03-08
WO2003053452A1 (de) 2003-07-03
DE50205968D1 (de) 2006-04-27
DE10161149A1 (de) 2003-06-26
US20050043271A1 (en) 2005-02-24
CN1604784A (zh) 2005-04-06
MXPA04005390A (es) 2005-10-18
JP2005513106A (ja) 2005-05-12
AU2002357972A1 (en) 2003-07-09
ES2259727T3 (es) 2006-10-16
EP1453523A1 (de) 2004-09-08

Similar Documents

Publication Publication Date Title
ATE318607T1 (de) Heparin-haltiges ophthalmikum
ATE442862T2 (de) Niederviskose konzentrierte proteinformulierungen
BRPI0402760A (pt) Composição microbicida
UY24572A1 (es) Conjugados peg - interferon alfa
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
BR0214309A (pt) Derivados aril-1,4-pirazina substituìdos
DE69907137D1 (de) Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner
NO20042260L (no) Hoy hastighets, ikke samtidig kontrollert database
DE60326133D1 (de) Iinitialisierung von beziehungen zwischen einrichtungen in einem Netzwerk
CY1112458T1 (el) Ενα αντισωμα ειδικο για διαλυτο baff για χρηση στην αντιμετωπιση του καρκινου
EP1575534A4 (en) D4.5 GLYCURONIDASE AND ITS USES
ATE412387T1 (de) Medizinische vorrichtungen
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
DK1033990T3 (da) 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
WO2003104576A3 (en) Structure having preinstalled utilities and amenities
DK1220852T3 (da) Substituerede diazepaner
BR0209084A (pt) Fluido dielétrico
DK1537065T3 (da) Analoger af D-vitamin
BR0104353A (pt) Taxanos heterosubstituìdos com acetato c7 como agentes antitumor
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
DK1532141T3 (da) 2-pyrrolidin-2-yl-[1,3,4]-oxadiazol-derivater og anvendelse deraf som antidepressiv
BRPI0500536A (pt) Composição antimicrobiana
FR2821560B1 (fr) Seringue, ou dispositif similaire